Jefferies Analyst: Oracle Down Yet in a Better Spot
Oracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...
This intro explains glide path asset allocation, describing how asset mix automatically becomes more conservative as you age.
24,533 articlesOracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
As AI workloads demand more network performance, Arista Networks and Broadcom stand out. This guide breaks down their...
Kyndryl’s latest quarterly results triggered a notable stock move as earnings fell short of expectations. This articl...
Upstart stock has taken a hard one-way trip downward, leaving some investors wondering if a rebound is possible. This...
Nexgel's Q1 2026 earnings reveal the early trajectory of the year. This analysis breaks down the numbers, explains th...
A high-stakes portfolio shuffle by a famed activist investor grabbed headlines. This piece breaks down what happened,...
An AI-focused stock rocks the market with a standout rally, prompting traders to reassess where AI breakthroughs are ...
Apple stock nears all-time as strong earnings and a growing Services business lift investor optimism. Here’s the late...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
As SpaceX captures headlines, a quieter but powerful growth wave is building in quantum computing. This guide highlig...
Taylor Morrison’s proxy shows a patient, staged sale to Berkshire Hathaway, highlighting a cautious appetite for big-...